(Q36890306)

16 August 2017

1 reference

title

Clinical pharmacokinetics of famotidine (English)

1 reference

16 August 2017

Clinical Pharmacokinetics of Famotidine (English)

1 reference

10.2165/00003088-199121030-00003

Crossref

DOI

https://api.crossref.org/works/10.2165/00003088-199121030-00003

18 November 2022

1 reference

1 reference

1 reference

10.2165/00003088-199121030-00003

https://api.crossref.org/works/10.2165/00003088-199121030-00003

18 November 2022

author name string

H. Echizen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1764869

18 November 2022

T. Ishizaki

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1764869

18 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1764869

18 November 2022

publication date

1 September 1991

1 reference

Clinical Pharmacokinetics

16 August 2017

published in

1 reference

16 August 2017

volume

21

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

178-194

1 reference

Effect of cimetidine and ranitidine on cardiovascular drugs

16 August 2017

cites work

1 reference

12 December 2020

Comparative effects of famotidine and cimetidine on antipyrine kinetics in healthy volunteers

1 reference

12 December 2020

Impaired bioavailability of famotidine given concurrently with a potent antacid

1 reference

12 December 2020

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models

1 reference

12 December 2020

The metabolism of antipyrine in patients with chronic renal failure

1 reference

12 December 2020

Clinical pharmacokinetics of cimetidine

1 reference

12 December 2020

In vitro studies on the interaction of famotidine with liver microsomal cytochrome P-450.

1 reference

12 December 2020

Current views on pathogenesis of peptic ulcer.

1 reference

12 December 2020

Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males

1 reference

12 December 2020

Comparative effect of famotidine and cimetidine on the pharmacokinetics of theophylline in normal volunteers

1 reference

12 December 2020

Drug interactions with cimetidine: an update

1 reference

12 December 2020

Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man

1 reference

12 December 2020

Effect of five structurally diverse H2-receptor antagonists on drug metabolism.

1 reference

12 December 2020

Pharmacokinetics of famotidine in elderly patients with and without renal insufficiency and in healthy young volunteers

1 reference

12 December 2020

Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases

1 reference

12 December 2020

Inhibition of renal creatinine secretion by cimetidine in humans

1 reference

12 December 2020

CSF concentrations of famotidine

1 reference

12 December 2020

Drugs for the Prevention of Peptic Ulcer Recurrence

1 reference

12 December 2020

Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function

1 reference

12 December 2020

Famotidine, a new H2-receptor antagonist. Effect on parietal, nonparietal, and pepsin secretion in man

1 reference

12 December 2020

Effects of hormones (calcitonin, GIP) and pharmacological antagonists (ranitidine and famotidine) on isolated rat parietal cells

1 reference

12 December 2020

Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients.

1 reference

12 December 2020

A comparison of the influence of famotidine and cimetidine on phenytoin elimination and hepatic blood flow

1 reference

12 December 2020

The effect of famotidine on renal function in patients with renal insufficiency

1 reference

12 December 2020

Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences

1 reference

12 December 2020

Antacid titration in the prevention of acute gastrointestinal bleeding: a controlled, randomized trial in 100 critically ill patients

1 reference

12 December 2020

Determination of famotidine in plasma, urine and gastric juice by high-performance liquid chromatography using disposable solid-phase extraction columns

1 reference

12 December 2020

Pharmacokinetic interactions of cimetidine 1987.

1 reference

12 December 2020

Plasma famotidine concentration versus intragastric pH in patients with upper gastrointestinal bleeding and in healthy subjects.

1 reference

12 December 2020

Antacid versus cimetidine in preventing acute gastrointestinal bleeding. A randomized trial in 75 critically ill patients

1 reference

12 December 2020

Famotidine does not affect indocyanine green disposition and serum bile acid levels in healthy subjects.

1 reference

12 December 2020

A consideration of the adverse effects of cimetidine.

1 reference

12 December 2020

Cimetidine in acute gastric mucosal bleeding: results of a double-blind randomized trial

1 reference

12 December 2020

Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamide.

1 reference

12 December 2020

Interaction of diazepam with famotidine and cimetidine, two H2-receptor antagonists.

1 reference

12 December 2020

Effects of antacids and food on absorption of famotidine

1 reference

12 December 2020

Frequent non-response to histamine H2-receptor antagonists in cirrhotics

1 reference

12 December 2020

Pharmacokinetics and dynamics of famotidine in patients with renal failure

1 reference

12 December 2020

Inhibition of gastric secretion by a new H2-antagonist, YM-11170 in healthy subjects

1 reference

12 December 2020

Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome

1 reference

12 December 2020

Effect of famotidine on hepatic hemodynamics and peptic ulcer

1 reference

12 December 2020

The plasma half-life of antipyrine in chromic uraemic and normal subjects

1 reference

12 December 2020

Cimetidine Suppression of Nocturnal Gastric Secretion in Active Duodenal Ulcer

1 reference

12 December 2020

Famotidine: a notable lack of drug interactions.

1 reference

12 December 2020

Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusion

1 reference

12 December 2020

Pharmacokinetics of famotidine in man

1 reference

12 December 2020

Histamine H2 receptor antagonists and blood alcohol levels

1 reference

12 December 2020

Interactions and Non-Interactions with Ranitidine

1 reference

12 December 2020

Effect of famotidine on oxidative drug metabolism

1 reference

12 December 2020

Famotidine pharmacokinetics following oral and intravenous administration in patients with liver disease: results of a preliminary study

1 reference

12 December 2020

Histamine H2-antagonist drug interactions in perspective: mechanistic concepts and clinical implications

1 reference

12 December 2020

Single-dose pharmacokinetics and bioavailability of famotidine in man. Results of multicenter collaborative studies

1 reference

12 December 2020

High-performance liquid chromatographic determination of famotidine in urine

1 reference

12 December 2020

Famotidine effects on theophylline pharmacokinetics in subjects affected by COPD. Comparison with cimetidine and placebo

1 reference

12 December 2020

Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome

1 reference

12 December 2020

Cimetidine excretion into breast milk

1 reference

12 December 2020

The effect of various dose regimens of famotidine on basal nocturnal and meal-stimulated gastric secretion.

1 reference

12 December 2020

CSF concentrations of ranitidine

1 reference

12 December 2020

Effects of age and chronic renal failure on the urinary excretion kinetics of famotidine in man.

1 reference

12 December 2020

Effects of H2-receptor antagonists on ethanol metabolism in Japanese volunteers

1 reference

12 December 2020

Disposition of famotidine in renal insufficiency

1 reference

12 December 2020

Interaction of Cimetidine with Liver Microsomes

1 reference

12 December 2020

Hemofiltrability of H2-receptor antagonist, famotidine, in renal failure patients

1 reference

12 December 2020

Urinary excretion kinetics of famotidine in rats

1 reference

12 December 2020

Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases

1 reference

12 December 2020

Famotidine. Pharmacokinetic properties and suppression of acid secretion in paediatric patients following cardiac surgery

1 reference

12 December 2020

Analytical method for the quantification of famotidine, an H2-receptor blocker, in plasma and urine

1 reference

12 December 2020

Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases

1 reference

12 December 2020

Clinical and pharmacological effectiveness of cimetidine in duodenal ulcer patients

1 reference

12 December 2020

24 hour intragastric acidity and single night-time dose of three H-2-blockers

1 reference

12 December 2020

Optimal therapeutic regimen of famotidine based on plasma concentrations in patients with chronic renal failure

1 reference

12 December 2020

Alteration by burn injury of the pharmacokinetics and pharmacodynamics of cimetidine in children

1 reference

12 December 2020

MK-208, a novel histamine H2-receptor inhibitor with prolonged antisecretory effect

1 reference

12 December 2020

A comparative evaluation of the transport of H2-receptor antagonists by the human and baboon placenta

1 reference

12 December 2020

Ranitidine kinetics and dynamics: I. Oral dose studies

1 reference

12 December 2020

10.2165/00003088-199121030-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

16 August 2017

1019492278

0 references

1 reference